Walgreens Boots Alliance is the largest retail pharmacy, health and daily living destination across the U.S. and Europe. Walgreens Boots Alliance and the companies in which it has equity method investments together have a presence in more than 25* countries and employ more than 385,000* people. The Company is a global leader in pharmacy-led, health and wellbeing retail and, together with the companies in which it has equity method investments, has more than 13,200* stores in 11* countries as well as one of the largest global pharmaceutical wholesale and distribution networks, with more than 390* distribution centers delivering to more than 230,000** pharmacies, doctors, health centers and hospitals each year in more than 20* countries. In addition, Walgreens Boots Alliance is one of the world’s largest purchasers of prescription drugs and many other health and wellbeing products. The Company’s size, scale, and expertise will help them to expand the supply of and address the rising cost of, prescription drugs in the U.S. and worldwide.
The creation of Walgreens Boots Alliance provides an opportunity to further accelerate the development of a fully integrated, global platform for the future to provide innovative ways to address health and wellness challenges. The Company is well positioned to expand customer offerings in existing markets and become the health and wellbeing partner of choice in emerging markets.
Walgreens Boots Alliance is included in Fortune magazine’s 2018 list of the World’s Most Admired Companies. This is the 25th consecutive year that Walgreens Boots Alliance or its predecessor company, Walgreen Co., has been named to the list.
Vista Exclusive Content
Pfizer & Eli Lilly Announce Positive Results in OA Pain Treatment Trial
Pfizer (PFE) is a leading global provider of anti-infective medicines, offering patients access to a diverse portfolio of more than 80 products. Pfizer and Eli Lilly have announced that their 16-week Phase 3 study in patients with osteoarthritis pain evaluating subcutaneous administration of tanezumab has
“All Good?” Vista Partners Weekly Market Update 7-21-18
Vista Partners has published “All Good?” Vista Partners Weekly Market Update 7-21-18 and is accessible on our Newsletters Page. Each issue is written by Managing Director, John Heerdink and speaks to the activities of the market, influencers and specific featured stories from Vista’s Coverage Universe that
Microsoft Announces Fiscal Year 2018 and Q4 Results
Microsoft Corp. announced their fiscal Q4 results on July 19, 2018. Revenue was reported at $30.1 billion, a 17% increase from the corresponding period of the last fiscal year. Operating income increased 35% at $10.4 billion. Net income was at $8.9 billion GAAP and $8.8
Company News Around The Web
20 July 2018 | 1:00 pm
Albertsons and Rite Aid have a message...
The combination would create a new retail giant valued at ro...
20 July 2018 | 1:00 pm
As Albertsons heads to pivotal vote in...
As Albertsons Cos. and Rite Aid head to an August vote over ...
18 July 2018 | 8:53 am
CVS, Walgreens, Walmart object to proposed tax...
A national lobbying group representing retail clinics and ur...
17 July 2018 | 3:10 pm
Is Johnson & Johnson Worth Another Look...
Ahead of its all-important second-quarter fiscal 2018 earnin...
17 July 2018 | 12:50 pm
3 Top Retail Stocks to Buy in...
Even in the face of a challenging retail environment, these ...
17 July 2018 | 12:07 pm
See what the IHS Markit Score report...
Short interest is low for WBA with fewer than 5% of shares o...
|Day Low - High|
|Year Low - High|